Finally, the study of polymorphisms of inflammatory mediators such as the IL6, CXCL8, and TNF genes deserves attention because it can be helpful in the choice of the proper pain therapy for the postoperative period following breast cancer surgery. This evidence concerns the gene TNF and breast carcinoma.